1. Home
  2. MCHX vs OVID Comparison

MCHX vs OVID Comparison

Compare MCHX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • OVID
  • Stock Information
  • Founded
  • MCHX 2003
  • OVID 2014
  • Country
  • MCHX United States
  • OVID United States
  • Employees
  • MCHX N/A
  • OVID N/A
  • Industry
  • MCHX Business Services
  • OVID Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • OVID Health Care
  • Exchange
  • MCHX Nasdaq
  • OVID Nasdaq
  • Market Cap
  • MCHX 84.3M
  • OVID 88.9M
  • IPO Year
  • MCHX 2004
  • OVID 2017
  • Fundamental
  • Price
  • MCHX $1.96
  • OVID $1.59
  • Analyst Decision
  • MCHX
  • OVID Strong Buy
  • Analyst Count
  • MCHX 0
  • OVID 4
  • Target Price
  • MCHX N/A
  • OVID $3.13
  • AVG Volume (30 Days)
  • MCHX 24.6K
  • OVID 5.1M
  • Earning Date
  • MCHX 10-30-2025
  • OVID 11-11-2025
  • Dividend Yield
  • MCHX N/A
  • OVID N/A
  • EPS Growth
  • MCHX N/A
  • OVID N/A
  • EPS
  • MCHX N/A
  • OVID N/A
  • Revenue
  • MCHX $47,534,000.00
  • OVID $6,651,000.00
  • Revenue This Year
  • MCHX N/A
  • OVID $1,086.57
  • Revenue Next Year
  • MCHX $7.56
  • OVID N/A
  • P/E Ratio
  • MCHX N/A
  • OVID N/A
  • Revenue Growth
  • MCHX N/A
  • OVID 1070.95
  • 52 Week Low
  • MCHX $1.26
  • OVID $0.24
  • 52 Week High
  • MCHX $2.40
  • OVID $2.01
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 50.62
  • OVID 59.52
  • Support Level
  • MCHX $1.65
  • OVID $1.62
  • Resistance Level
  • MCHX $1.98
  • OVID $2.01
  • Average True Range (ATR)
  • MCHX 0.09
  • OVID 0.19
  • MACD
  • MCHX 0.00
  • OVID 0.02
  • Stochastic Oscillator
  • MCHX 72.57
  • OVID 54.17

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: